KSC Equity Snapshot
003520 Weekly Equity Report
Yungjin Pharm. Co., Ltd.
What the company does
Yungjin Pharm. Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. The company offers cephalosporin antibiotic, antipsychotic, cardiovascular, gastrointestinal, metabolic, neuropsychiatry, respiratory, infectious, anti-inflammatory and analgesics, nutritional supplement, and urology products. It also provides vitamins, minerals, and other products; and APIs. The company was founded in 1952 and is headquartered in Seoul, South Korea. Yungjin Pharm. Co., Ltd. operates as a subsidiary of KT&G Corporation.
What the weekly tape is saying
003520 closed the latest completed week at 1,265 KRW. The 4-week return is -18.6% and the 12-week return is -29.5%. Trend Signal is inactive, Market Dynamics is -1.68. Setup signature: Risk-first tape with a 8/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,802 KRW
- Vs Trend Line
- -29.8%
- Fair Value
- 2,100 KRW
- Vs Fair Value
- -39.8%
- 52W High
- 2,450 KRW
- 52W Low
- 1,203 KRW
- Drawdown
- -48.4%
- Range Position
- 5.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 9
- 52W Active Breadth
- 17.3%
- Sector Scope
- KR Healthcare
- Sector Rank
- 29 of 63
- Sector Percentile
- 54.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
KR Healthcare
- Tracked Peers
- 63
- 4W Rank
- 53 of 63
- Avg 1W
- -1.0%
- Avg 4W
- -12.7%
- Trend Breadth
- 1.6%
- Positive MD
- 6.3%
KR Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 44
- 4W Rank
- 37 of 44
- Avg 1W
- -1.3%
- Avg 4W
- -12.9%
- Trend Breadth
- 2.3%
- Positive RS
- 0.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.68
- 4W MD Change
- -67.9%
- Relative Strength
- -66.07
- 4W RS Change
- -11.7%
- Expectation
- Negative
- Probability
- 41.26%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.1M
- 13W Average
- 1.9M
- 52W Average
- 2.4M
- Vs 13W
- 0.6x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.4%
- 52W Volatility
- 3.5%
- Upside Weeks
- 19
- Downside Weeks
- 33
- Downside Breadth
- 63.5%
- Avg Gain / Loss
- 2.6% / -3.0%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- KSC
- Country
- KR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- KRW
- Market Cap
- 232.1B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,265 KRW | -0.2% | 1,802 KRW | 2,100 KRW | -1.68 | -66.07 | 1.1M | Off |
| 5 Jun 2026 | 1,267 KRW | -2.5% | 1,828 KRW | 2,109 KRW | -1.59 | -66.99 | 2.1M | Off |
| 29 May 2026 | 1,299 KRW | -11.8% | 1,851 KRW | 2,118 KRW | -1.52 | -68.23 | 1.9M | Off |
| 22 May 2026 | 1,472 KRW | -5.3% | 1,876 KRW | 2,128 KRW | -1.28 | -62.12 | 1.9M | Off |
| 15 May 2026 | 1,554 KRW | -6.4% | 1,894 KRW | 2,137 KRW | -1.00 | -59.15 | 2.7M | Off |
| 8 May 2026 | 1,661 KRW | -6.2% | 1,908 KRW | 2,145 KRW | -0.66 | -57.41 | 2.3M | Off |
| 1 May 2026 | 1,770 KRW | -2.4% | 1,919 KRW | 2,153 KRW | -0.72 | -49.47 | 1.1M | Off |
| 24 Apr 2026 | 1,813 KRW | -3.8% | 1,926 KRW | 2,161 KRW | -0.97 | -48.25 | 2.1M | Off |
| 17 Apr 2026 | 1,884 KRW | 7.4% | 1,930 KRW | 2,168 KRW | -1.19 | -44.77 | 1.8M | Off |
| 10 Apr 2026 | 1,755 KRW | 2.0% | 1,934 KRW | 2,175 KRW | -1.48 | -46.57 | 1.3M | Off |
| 3 Apr 2026 | 1,721 KRW | -3.8% | 1,943 KRW | 2,184 KRW | -1.35 | -43.88 | 1.4M | Off |
| 27 Mar 2026 | 1,789 KRW | -0.3% | 1,954 KRW | 2,193 KRW | -1.04 | -43.20 | 1.8M | Off |
| 20 Mar 2026 | 1,795 KRW | -0.9% | 1,961 KRW | 2,200 KRW | -0.48 | -47.17 | 2.4M | Off |
| 13 Mar 2026 | 1,811 KRW | -4.2% | 1,969 KRW | 2,207 KRW | -0.33 | -44.63 | 2.0M | Off |